Michael B. Hoffman, Director at Annovis Bio, Inc. (ANVS), bought 1,951,220 shares at $2.05 ($4.0M) on 2025-10-28, disclosed to the SEC on 2025-11-12.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $2.05 | 975,610 | $2.0M | 50.0% |
| 2 | $2.05 | 975,610 | $2.0M | 50.0% |
| Total | $2.05 avg | 1,951,220 | $4.0M | 100% |
| Filing → |
| ANVS | BUY | 2025-12-08 | $194K | — | Filing → |
| ANVS | BUY | 2025-11-25 | $276K | — | Filing → |
| ANVS | BUY | 2025-11-21 | $70K | — | Filing → |